Deep Dive: A Capital Planning Executive’s Perspective on Trends In the BioPharma Industry

Deep Dive: A Capital Planning Executive’s Perspective on Trends In the BioPharma Industry The biotech and pharmaceutical sectors flourished in 2021 due to a low-interest rate environment and strong pandemic-driven demand, achieving top-line growth of over 30%. However, 2022 proved to be quieter as financing waned and large companies shifted their focus to divesting non-core […]